We are live on ! Find out more
TL

Tirschwell & Loewy Portfolio holdings

AUM $731M
1-Year Est. Return 15.44%
This Fund
S&P 500
This Quarter Est. Return
+11.54%
1 Year Est. Return
+15.44%
3 Year Est. Return
+77.99%
5 Year Est. Return
+97.61%
10 Year Est. Return
–
AUM
$800M
AUM Growth
+$47.7M
Cap. Flow
-$30.3M
Cap. Flow %
-3.79%
Top 10 Hldgs %
45.05%
Holding
78
New
2
Increased
10
Reduced
41
Closed
7

Top Buys

Rank Stock Value
1
NVRO
NEVRO CORP.
NVRO
+$1.33M
2
BF.B icon
Brown-Forman Class B
BF.B
+$1.01M
3
DIS icon
Walt Disney
DIS
+$689K
4
ITW icon
Illinois Tool Works
ITW
+$340K
5
STT icon
State Street
STT
+$336K

Top Sells

Rank Stock Value
1
XRAY icon
Dentsply Sirona
XRAY
+$9.62M
2
FEZ icon
State Street SPDR EURO STOXX 50 ETF
FEZ
+$4.45M
3
INGN icon
Inogen
INGN
+$2.22M
4
IDXX icon
Idexx Laboratories
IDXX
+$1.85M
5
BIIB icon
Biogen
BIIB
+$1.61M

Sector Composition

Rank Sector Weight
1 Healthcare 47.62%
2 Technology 10.62%
3 Industrials 9.55%
4 Consumer Discretionary 6.27%
5 Financials 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TIF
1
DELISTED
Tiffany & Co.
TIF
$43.5M 5.43%
337,140
-3,050
-0.9% -$399K
CGNX icon
2
Cognex
CGNX
$10.5B
$41.3M 5.16%
739,610
-2,065
-0.3% -$106K
DXCM icon
3
DexCom
DXCM
$29.2B
$41M 5.12%
1,146,216
-14,600
-1% -$453K
INGN icon
4
Inogen
INGN
$173M
$37.7M 4.71%
154,495
-9,620
-6% -$2.22M
IDXX icon
5
Idexx Laboratories
IDXX
$44.5B
$35.9M 4.48%
143,665
-7,615
-5% -$1.85M
MA icon
6
Mastercard
MA
$484B
$34.6M 4.32%
155,341
-325
-0.2% -$67.8K
ABMD
7
DELISTED
Abiomed Inc
ABMD
$33.2M 4.15%
73,880
-60
-0.1% -$23.7K
PODD icon
8
Insulet
PODD
$11.6B
$31.5M 3.94%
297,580
-6,585
-2% -$617K
NEOG icon
9
Neogen
NEOG
$2.18B
$31.4M 3.92%
876,834
-35,226
-4% -$1.5M
ADI icon
10
Analog Devices
ADI
$181B
$30.4M 3.8%
328,870
-3,975
-1% -$382K
RTN
11
DELISTED
Raytheon Company
RTN
$27.7M 3.46%
134,109
-30
-0% -$5.97K
JNJ icon
12
Johnson & Johnson
JNJ
$599B
$27.1M 3.39%
196,050
-1,195
-0.6% -$159K
DHR icon
13
Danaher
DHR
$142B
$26.9M 3.37%
279,649
+1,596
+0.6% +$145K
HON icon
14
Honeywell
HON
$71.7B
$26.4M 3.3%
175,856
-94
-0.1% -$13.3K
BF.B icon
15
Brown-Forman Class B
BF.B
$12.1B
$26.3M 3.28%
519,874
+19,510
+4% +$1.01M
BIIB icon
16
Biogen
BIIB
$29.5B
$23.6M 2.94%
66,683
-4,674
-7% -$1.61M
ROST icon
17
Ross Stores
ROST
$75.6B
$21.5M 2.69%
217,029
-2,730
-1% -$251K
NVO
18
Novo Nordisk
NVO
$219B
$19.2M 2.4%
815,350
+460
+0.1% +$11.2K
SBUX icon
19
Starbucks
SBUX
$119B
$17.8M 2.22%
312,481
-11,257
-3% -$595K
HSIC icon
20
Henry Schein
HSIC
$9.82B
$16.9M 2.11%
252,760
-1,173
-0.5% -$73.1K
AMGN icon
21
Amgen
AMGN
$197B
$15.7M 1.97%
75,925
-520
-0.7% -$102K
MTD icon
22
Mettler-Toledo International
MTD
$25.7B
$14.4M 1.79%
23,575
+225
+1% +$132K
NVRO
23
DELISTED
NEVRO CORP.
NVRO
$11.1M 1.39%
194,470
+21,300
+12% +$1.33M
ABBV icon
24
AbbVie
ABBV
$448B
$11.1M 1.38%
116,950
-6,750
-5% -$640K
ITW icon
25
Illinois Tool Works
ITW
$78.2B
$10.7M 1.33%
75,591
+2,415
+3% +$340K
1
2 3

Similar funds

IAS
INR Advisory Services Media, Pennsylvania $786M AUM 2.23% 1-Year Est. Return
ACM
Aviance Capital Management Sarasota, Florida $668M AUM 6.48% 1-Year Est. Return
MFBTD
MB Financial Bank - Trust Department Rosemont, Illinois $816M AUM 5.49% 1-Year Est. Return
SGAM
Steinberg Global Asset Management Boca Raton, Florida $639M AUM 11.04% 1-Year Est. Return
AB
AT Bancorp Dubuque, Iowa $823M AUM 0.35% 1-Year Est. Return
NTC
NF Trinity Capital Central, Hong Kong $626M AUM 3.16% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
DSI
Daiwa SB Investments Tokyo, Japan $506M AUM 11% 1-Year Est. Return

Tirschwell & Loewy's Q3 2018 Portfolio in Review

As of Q3 2018, Tirschwell & Loewy held 78 positions worth $800M, up 6.3% from $752M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Tirschwell & Loewy withdrew a net $30.3M in Q3 2018, closing 7 positions and reducing 41 holdings. Its most notable exit was State Street SPDR EURO STOXX 50 ETF, an estimated $4.45M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 47% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tirschwell & Loewy opened a new position in Pfizer worth $220K.

  • Tirschwell & Loewy's largest Q3 2018 buy was Pfizer: 5,268 shares worth $220K.
  • Tirschwell & Loewy added most to NEVRO CORP. in Q3 2018, an estimated $1.33M increase.
  • Tirschwell & Loewy's biggest Q3 2018 reduction was Dentsply Sirona, cutting an estimated $9.62M.
  • Tirschwell & Loewy fully exited State Street SPDR EURO STOXX 50 ETF in Q3 2018, selling an estimated $4.45M.
  • Tirschwell & Loewy's ten largest holdings make up 45% of its $800M portfolio in Q3 2018.
  • Tirschwell & Loewy opened 2 new positions and closed 7 in Q3 2018.
  • Tirschwell & Loewy's portfolio value rose 6.3% quarter-over-quarter to $800M.

Based on Tirschwell & Loewy's 13F filing for Q3 2018, filed 7 Nov 2018.